Canertinib dihydrochloride
| CAS No. | 289499-45-2 | Cat. No. | BCP01902 |
| Name | Canertinib dihydrochloride | ||
| Synonyms | Canertinib 2HCl;CI-103;CI 103;CI103; | ||
| Formula | C24H27Cl3FN5O3 | M. Wt | 558.86 |
| Description | Canertinib Dihydrochloride is the hydrochloride salt of an orally bio-available quinazoline with potential antineoplastic and radiosensitizing activities. Canertinib binds to the intracellular domains of epidermal growth factor receptor tyrosine kinases (ErbB family), irreversibly inhibiting their signal transduction functions and resulting in tumor cell apoptosis and suppression of tumor cell proliferation. This agent also acts as a radiosensitizing agent and displays synergistic activity with other chemotherapeutic agents. | ||
| Related Products | 267243-28-7（Canertinib） | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase Jak/Stat Pathway | ||
| Targets | EGFR HER2 | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.